Two Sigma Securities’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
Other funds holding SABS
Two Sigma Securities's SABS Position: Q3 2026 in Review
Two Sigma Securities opened a new position in SAB Biotherapeutics (SABS) in Q3 2026: 15,663 shares worth $49.7K. The stake represents ﹤0.01% of the portfolio and ranks #1409 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in SABS as recently as Q2 2023.
Two Sigma Securities first reported a position in SABS in Q1 2023 and has held it in 3 quarters since. 76 funds tracked by Wall St. Rank hold SABS as of Q3 2026.
- Two Sigma Securities held 15,663 shares of SAB Biotherapeutics worth $49.7K as of Q3 2026.
- SAB Biotherapeutics was a new Two Sigma Securities position in Q3 2026.
- SAB Biotherapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q3 2026, its #1409 holding.
- Two Sigma Securities first reported a position in SAB Biotherapeutics in Q1 2023 and has held it in 3 quarters since.
- 76 funds tracked by Wall St. Rank held SAB Biotherapeutics as of Q3 2026.
Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.